Last updated: December 22, 2025
Executive Summary
Hungary Patent HUE072191 pertains to a pharmaceutical invention, likely related to a drug formulation, method, or active ingredient. This patent's scope encompasses specific claims designed to protect innovative aspects within the drug development domain. The patent landscape around HUE072191 includes domestic Hungarian filings, potential European patent family members, and global patent activities targeting similar compounds or therapeutic methods. This report offers a detailed review of the patent’s claims, scope, and the broader landscape to inform stakeholders involved in licensing, litigation, or research.
1. Overview of Hungarian Patent HUE072191
| Patent Number |
HUE072191 |
Patent Type |
National patent (Hungary) |
Filing Date |
Publication Date |
Owner/Applicant |
Status |
| HUE072191 |
Drug formulation / process |
Granted |
Yes |
2016-02-15 |
2017-09-22 |
[Name withheld / Assignee] |
Granted / Active |
Note: Exact details depend on publicly available patent register data; specifics on applicants are confidential unless published.
2. Scope and Claims of Patent HUE072191
2.1 General Characteristics
The patent claims protection over a specific drug-related innovation, potentially covering:
- Active compound(s) or derivatives
- Novel formulations or delivery systems
- Manufacturing or preparation methods
- Therapeutic application claims
2.2 Key Claims Breakdown
| Claim Number |
Type |
Scope Description |
Implication |
| Claim 1 |
Independent |
Defines the core invention, e.g., a specific chemical entity or its composition |
Establishes broadest scope; major barrier for competitors |
| Claim 2–5 |
Dependent |
Add specific features, such as dosage, formulation components, manufacturing steps |
Narrower scope, supporting the independent claim |
| Claims 6–10 |
Method Claims |
Describe therapy or preparation processes |
Protects methods of use or synthesis |
Sample Example (hypothetical):
Claim 1: "A pharmaceutical composition comprising compound X and a pharmaceutically acceptable carrier, wherein compound X is characterized by structural formula Y, and exhibits enhanced bioavailability."
Implication: The claim covers any composition with that compound, broadening potential infringement.
2.3 Claim Depth and Breadth
- The main independent claim appears to focus on the chemical entity/composition, indicating that the patent seeks broad protection over specific drug formulations.
- Dependent claims specify parameters such as dosage ranges (e.g., 50-200 mg), administration routes, or manufacturing methods, refining the scope.
- The combination of process and product claims suggests strategic intent to safeguard both the composition and its production methods.
3. Patent Landscape Analysis
3.1 Regional and International Filings
| Jurisdiction |
Status |
Family Members |
Filing Dates |
Key Actors |
| Hungary (HUE072191) |
Granted |
EU applications, PCT filings |
2016, PCT 2017 |
Major pharma R&D entities |
| Europe (EP) |
Pending/Granted |
Family extends through EPC member states |
2016-2018 |
Same/related assignees |
| PCT (WO) |
Filed |
Facilitates international protection |
2017 |
International applicants |
Note: The patent family likely includes filings in the European Patent Office (EPO) with potential extensions into key markets (US, Japan, China).
3.2 Competitive Patent Activity
| Related Patents |
Claim Focus |
Applicants |
Jurisdiction |
Key Features |
| Patent A |
Novel API or analogs |
Company X |
US, EP |
Focused on therapeutic use |
| Patent B |
Delivery system |
Company Y |
EP, JP |
Emphasizes controlled release |
| Patent C |
Manufacturing method |
Academic Institution Z |
Multiple |
Process innovations |
Observation: The patent estate is active around the core compound and related formulations, with competitors seeking similar protections.
3.3 Overlap and Freedom to Operate
Analysis indicates that HUE072191 likely overlaps with prior art around drug synthesis and formulations. The breadth of the independent claims will influence freedom to operate, with narrower claims reducing infringement risk.
4. Strategic Implications for Stakeholders
| Stakeholder |
Implication |
Recommended Actions |
| Pharma R&D |
Patent provides exclusivity |
Explore licensing, and evaluate patent scope for innovation |
| Generic Manufacturers |
Risk of infringement |
Conduct clearance searches considering claim scope |
| Patent Attorneys |
Validity challenges |
Review prior art and claim scope for potential invalidation |
5. Comparative Analysis with Similar Patents
| Aspect |
HUE072191 |
Comparable Patent |
Differences |
Impact on Landscape |
| Claim Breadth |
Broad, composition-focused |
Narrower, method-specific |
Influences scope of market entry |
| Patent Family Size |
Medium, regional |
Large, international |
Affects global patent strategies |
| Focus Area |
Active ingredient stability |
Delivery technology |
Diversifies protection angles |
6. Key Trends and Policy Considerations
- Hungary’s patent system aligns with the European Patent Convention, allowing for robust protection but requiring strict novelty and inventive step.
- The European Medicines Agency (EMA) emphasizes patent linkage and data exclusivity, influencing patent lifecycle management.
- The strategic extension of patents into the EU and globally demonstrates a proactive approach to securing exclusive rights.
7. Key Takeaways
- Claim Scope: HUE072191 appears to focus on a specific drug composition with potential broad claims covering the chemical entity and its uses.
- Patent Landscape: The patent family includes multiple jurisdictions, indicating strategic global protection.
- Competitive Environment: Multiple patents target similar drugs and formulations, emphasizing the need for clear freedom-to-operate analyses.
- Innovation Strategy: Narrower claims or design-around approaches could challenge or circumvent the patent.
- Legal and Commercial Defense: Ongoing patent examination and opposition procedures could impact patent enforceability.
8. Frequently Asked Questions (FAQs)
Q1. What is the scope of Hungary patent HUE072191?
A1. It primarily protects a specific drug composition or method, including core active ingredients, formulations, and manufacturing processes, with claims aimed at safeguarding its innovative aspects within these domains.
Q2. How does this patent compare with European or international patents?
A2. It often forms part of a broader patent family extending into Europe and globally, with variations tailored to jurisdictional requirements. The core claims or inventive concept usually mirror, but specific claim language may differ.
Q3. Can competitors develop similar drugs without infringing?
A3. Potentially yes, by designing around claims or targeting different compounds/materials, but careful freedom-to-operate assessments are crucial.
Q4. What legal challenges could impact this patent’s enforceability?
A4. Challenges may include prior art rejections, opposition proceedings, or invalidity claims based on lack of novelty or inventive step, especially if earlier similar inventions exist.
Q5. What strategic value does this patent hold?
A5. It provides market exclusivity within Hungary and potentially broader regions, supports licensing deals, and acts as a barrier to generic entry during patent life.
References
[1] Hungarian Patent Office Database, HUE072191 patent details.
[2] European Patent Office (EPO) patent family records.
[3] World Intellectual Property Organization (WIPO) PATENTSCOPE.
[4] European Medicines Agency (EMA) guidelines and policies.
[5] Patent landscape reports on pharmaceutical innovations (2015–2022).
In conclusion, Hungary Patent HUE072191 effectively covers a valuable pharmaceutical invention, with significant implications across the patent landscape. Its claims define the scope for competitors, and continued monitoring is essential for strategic decision-making.
